ORPN - Bioblast Pharma Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.5600
+0.0600 (+4.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.5000
Open1.5000
Bid1.5900 x 1000
Ask1.6400 x 2900
Day's Range1.4600 - 1.5900
52 Week Range1.0300 - 5.9900
Volume34,197
Avg. Volume84,913
Market Cap5.214M
Beta (3Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-1.7940
Earnings DateFeb 22, 2018 - Feb 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.00
Trade prices are not sourced from all markets
  • GlobeNewswire3 months ago

    Bioblast Pharma Ltd. Corporate and Management Update

    Bioblast Pharma Ltd. (ORPN) is providing an update on business development activities as well as notice of an organization change that affects members of the board and management. As previously announced, the Company is seeking a commercial partner for its investigational proprietary intravenous (IV) form of trehalose 90 mg/mL solution (trehalose), which has been studied in humans with ocular pharyngeal muscular dystrophy (OPMD) and Spinocerebellar Ataxia Type 3 (SCA3). Although no partnership or other arrangement has been concluded, the Company is working diligently to find such a partner, as well as to enter into a merger agreement with a third party.

  • Who Are The Top Investors In Bioblast Pharma Ltd (NASDAQ:ORPN)?
    Simply Wall St.5 months ago

    Who Are The Top Investors In Bioblast Pharma Ltd (NASDAQ:ORPN)?

    Today, I will be analyzing Bioblast Pharma Ltd’s (NASDAQ:ORPN) recent ownership structure, an important but not-so-popular subject among individual investors. When it comes to ownership structure of a company, theRead More...

  • Benzinga6 months ago

    Benzinga Pro's 6 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! athenahealth, Inc (NASDAQ: ATHN ) stock was trading ...

  • What Kind Of Risk Should You Expect For Bioblast Pharma Ltd (NASDAQ:ORPN)?
    Simply Wall St.6 months ago

    What Kind Of Risk Should You Expect For Bioblast Pharma Ltd (NASDAQ:ORPN)?

    If you are looking to invest in Bioblast Pharma Ltd’s (NASDAQ:ORPN), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...

  • Should You Be Concerned About Bioblast Pharma Ltd’s (NASDAQ:ORPN) Investors?
    Simply Wall St.8 months ago

    Should You Be Concerned About Bioblast Pharma Ltd’s (NASDAQ:ORPN) Investors?

    I am going to take a deep dive into Bioblast Pharma Ltd’s (NASDAQ:ORPN) most recent ownership structure, not a frequent subject of discussion among individual investors. A company’s ownership structureRead More...

  • Benzinga9 months ago

    ICYMI: Shutterfly Downgrade, BioBlast Price Action, Blockchain ETFs

    In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 17, 2018. Blockchain ETFs’ Inaugural Trading Session Wayne Duggan breaks down the arrival of new ETFs - Reality Shares ...

  • Should You Invest In The Healthcare Stock Bioblast Pharma Ltd (ORPN)?
    Simply Wall St.last year

    Should You Invest In The Healthcare Stock Bioblast Pharma Ltd (ORPN)?

    Bioblast Pharma Ltd (NASDAQ:ORPN), a USD$7.59M small-cap, operates in the healthcare industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as an aging population,Read More...

  • Associated Presslast year

    Bio Blast reports 3Q loss

    The Tel Aviv, Israel-based company said it had a loss of 32 cents per share. The company's shares closed at $2.27. A year ago, they were trading at $7.15. _____ This story was generated by Automated Insights ...